Overview
Glycomet GP 500 mg/2 mg Tablets combine two effective anti-diabetic agents: Metformin (500 mg) and Glimepiride (2 mg). This dual-action oral medication is prescribed for the management of type 2 diabetes mellitus, especially in patients whose blood glucose is not adequately controlled with monotherapy. Metformin improves insulin sensitivity and reduces glucose production in the liver, while Glimepiride stimulates the pancreas to release insulin, together helping maintain better glycemic control.





